Flagship Wealth Advisors’s AbbVie ABBV Stock Holding History

Flagship Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$528K	Sell	2,844 -2,153	-43%	-$478K	0.23%	59
2025 Q4	$1.14M	Buy	4,997 +1,538	+44%	+$350K	0.33%	48
2025 Q3	$801K	Sell	3,459 -1,422	-29%	-$290K	0.26%	57
2025 Q2	$906K	Buy	4,881 +113	+2%	+$21K	0.34%	50
2025 Q1	$999K	Sell	4,768 -19	-0.4%	-$3.69K	0.42%	43
2024 Q4	$851K	Buy	+4,787	New	+$880K	0.5%	38

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Wealth Advisors's ABBV Position: Q1 2026 in Review

Flagship Wealth Advisors reduced its AbbVie (ABBV) stake by 43% in Q1 2026, selling an estimated $478K and leaving 2,844 shares worth $528K. The position accounts for 0.23% of the portfolio, ranked #59.

Flagship Wealth Advisors first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.14M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Flagship Wealth Advisors held 2,844 shares of AbbVie worth $528K as of Q1 2026.
Flagship Wealth Advisors sold 2,153 AbbVie shares in Q1 2026, an estimated $478K.
AbbVie made up 0.23% of Flagship Wealth Advisors's portfolio in Q1 2026, its #59 holding.
Flagship Wealth Advisors first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
Flagship Wealth Advisors's AbbVie position peaked at $1.14M in Q4 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Flagship Wealth Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.